100% Quality Guarantee
PhD-Level Technical Support
Anti-BAFF belimumab biosimilar mAb HDBS0044
Key Features

Belimumab Biosimilar (BAFF) Antibody (HDBS0044)

SKU HDBS0044
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein BAFF
Reactivity Human
Host Species Humanized
Isotype IgG1
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Belimumab Biosimilar (BAFF) Antibody (HDBS0044)

The BAFF (Belimumab Biosimilar) Monoclonal Antibody (HDbs0044) is a cutting-edge tool for researchers studying B-cell activating factor (BAFF), a key protein involved in B-cell survival and maturation. This antibody, developed as a biosimilar to the well-known drug Belimumab, is optimized for use in a variety of applications, including ELISA, Western blot, and immunohistochemistry.BAFF, also known as B-lymphocyte stimulator, is a cytokine that plays a crucial role in regulating B-cell function and antibody production. Dysregulation of BAFF signaling has been linked to autoimmune diseases, such as systemic lupus erythematosus, making it a promising target for therapeutic intervention.

The Anti-BAFF Monoclonal Antibody (HDbs0044) specifically binds to BAFF, allowing for the precise detection and quantification of this protein in complex biological samples.By using this antibody, researchers can gain valuable insights into the role of BAFF in various disease states and potentially discover new therapeutic approaches for treating autoimmune disorders and other conditions characterized by immune dysregulation. Its high specificity and sensitivity, along with its versatility in multiple assay formats, make the Anti-BAFF Monoclonal Antibody (HDbs0044) a valuable tool for advancing research in immunology and drug development.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose